Commentary

Modulating nuclear receptor function: may the phos be with you
Dalei Shao, Mitchell A. Lazar
Dalei Shao, Mitchell A. Lazar
View: Text | PDF

Modulating nuclear receptor function: may the phos be with you

Abstract

Authors

Dalei Shao, Mitchell A. Lazar

×
Myocyte hypertrophy: the long and winding RhoA’d
Toren Finkel
Toren Finkel
View: Text | PDF
Not a mouse stirring: deletion of the EP2 and love’s labor’s lost
Sandra Austin, Garret A. FitzGerald
Sandra Austin, Garret A. FitzGerald
View: Text | PDF

Not a mouse stirring: deletion of the EP2 and love’s labor’s lost

Abstract

Authors

Sandra Austin, Garret A. FitzGerald

×
Complexity in simplicity: monogenic disorders and complex cardiomyopathies
Ju Chen, Kenneth R. Chien
Ju Chen, Kenneth R. Chien
View: Text | PDF
At last, direct evidence that lipoxygenases play a role in atherogenesis
Daniel Steinberg
Daniel Steinberg
View: Text | PDF
Target acquisition and acute promyelocytic leukemia
David A. Egan, Ronald M. Evans
David A. Egan, Ronald M. Evans
View: Text | PDF

Target acquisition and acute promyelocytic leukemia

Abstract

Authors

David A. Egan, Ronald M. Evans

×
What happens to ΔF508 in vivo?
Mitchell Drumm
Mitchell Drumm
View: Text | PDF

What happens to ΔF508 in vivo?

Abstract

Authors

Mitchell Drumm

×
Finally, CTLA4Ig graduates to the clinic
Mohamed H. Sayegh
Mohamed H. Sayegh
View: Text | PDF

Finally, CTLA4Ig graduates to the clinic

Abstract

Authors

Mohamed H. Sayegh

×
Beating the odds: a cardiomyocyte cell line at last
Jeffrey M. Leiden
Jeffrey M. Leiden
View: Text | PDF

Beating the odds: a cardiomyocyte cell line at last

Abstract

Authors

Jeffrey M. Leiden

×
Accessory factors and the regulation of epithelial sodium channel activity
David G. Warnock
David G. Warnock
View: Text | PDF

No posts were found with this tag.

Advertisement